{
  "ptid_time": "941_S_5124_2013-04-09",
  "img_path": "/data/qiuhui/data/adni/images/941_S_5124/2013-04-09/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 4,792 mm³, 32.6% below the reference mean. With a Z-score of -2.99 (0.1th percentile), this represents significant atrophy. ",
  "text_data": "Age is 76.7 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Alcohol Abuse; Smoking; Malignancy; Major Surgical Procedures. MMSE: 26.0. MoCA: 25.0. Logical Memory: 11.0. Laboratory findings: MCHC: 36.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.16 SUVR (normal ); Total tau: 340.90 pg/mL (mild elevated); Phosphorylated tau: 30.81 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is significantly reduced (32.6% below mean, Z-score -2.99), which is strongly suggestive of neurodegeneration. Despite normal cognition (MMSE 26, MoCA 25) and no APOE4 risk allele, mild elevations in T-tau and P-tau may indicate early pathological changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are normal, but hippocampal atrophy and mild biomarker abnormalities suggest early decline.)",
  "timestamp": "2025-07-26T17:43:13.021143"
}